Integration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC) - a Phase II Trial
2005 ◽
Vol 23
(16_suppl)
◽
pp. 5506-5506
◽
Keyword(s):
Phase Ii
◽